von Scheibler E, Van Eeghen A, De Koning T, Kuijf M, Zinkstok J, Muller A
Mov Disord Clin Pract. 2023; 10(1):17-31.
PMID: 36699000
PMC: 9847320.
DOI: 10.1002/mdc3.13577.
Aljassim N, Alfadhel M, Nashabat M, Eyaid W
Mol Genet Metab Rep. 2020; 25:100644.
PMID: 32939339
PMC: 7479436.
DOI: 10.1016/j.ymgmr.2020.100644.
Radcliff A, Heidari M, Field A, Duncan I
PLoS One. 2020; 15(1):e0228109.
PMID: 31978144
PMC: 6980670.
DOI: 10.1371/journal.pone.0228109.
Cui J, Wang Y, Zhang H, Cui X, Wang L, Zheng H
Medicine (Baltimore). 2019; 98(39):e17334.
PMID: 31574870
PMC: 6775410.
DOI: 10.1097/MD.0000000000017334.
Zhang X, Hou C, Liu P, Chen L, Liu Y, Tang P
Front Neurol. 2019; 9:1162.
PMID: 30687218
PMC: 6333660.
DOI: 10.3389/fneur.2018.01162.
Hyperhomocysteinemia as a Risk Factor for Vascular Contributions to Cognitive Impairment and Dementia.
Price B, Wilcock D, Weekman E
Front Aging Neurosci. 2018; 10:350.
PMID: 30429785
PMC: 6220027.
DOI: 10.3389/fnagi.2018.00350.
Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency.
Huemer M, Diodato D, Schwahn B, Schiff M, Bandeira A, Benoist J
J Inherit Metab Dis. 2016; 40(1):21-48.
PMID: 27905001
PMC: 5203859.
DOI: 10.1007/s10545-016-9991-4.
Treatment with Mefolinate (5-Methyltetrahydrofolate), but Not Folic Acid or Folinic Acid, Leads to Measurable 5-Methyltetrahydrofolate in Cerebrospinal Fluid in Methylenetetrahydrofolate Reductase Deficiency.
Knowles L, Morris A, Walter J
JIMD Rep. 2016; 29:103-107.
PMID: 26898294
PMC: 5059208.
DOI: 10.1007/8904_2016_529.
Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency.
Huemer M, Mulder-Bleile R, Burda P, Froese D, Suormala T, Ben Zeev B
J Inherit Metab Dis. 2015; 39(1):115-24.
PMID: 26025547
PMC: 6551224.
DOI: 10.1007/s10545-015-9860-6.
Reversal of respiratory failure in both neonatal and late onset isolated remethylation disorders.
Broomfield A, Abulhoul L, Pitt W, Jameson E, Cleary M
JIMD Rep. 2014; 16:51-6.
PMID: 24997712
PMC: 4221296.
DOI: 10.1007/8904_2014_319.
Cerebral folate deficiency.
Hyland K, Shoffner J, Heales S
J Inherit Metab Dis. 2010; 33(5):563-70.
PMID: 20668945
DOI: 10.1007/s10545-010-9159-6.
Isolated remethylation disorders: do our treatments benefit patients?.
Schiff M, Benoist J, Tilea B, Royer N, Giraudier S, de Baulny H
J Inherit Metab Dis. 2010; 34(1):137-45.
PMID: 20490923
DOI: 10.1007/s10545-010-9120-8.
Folate and depression--a neglected problem.
Young S
J Psychiatry Neurosci. 2007; 32(2):80-2.
PMID: 17353937
PMC: 1810582.
Folate for depressive disorders.
Taylor M, Carney S, Geddes J, Goodwin G
Cochrane Database Syst Rev. 2003; (2):CD003390.
PMID: 12804463
PMC: 6991158.
DOI: 10.1002/14651858.CD003390.
Biochemical pathogenesis of subacute combined degeneration of the spinal cord and brain.
Surtees R
J Inherit Metab Dis. 1993; 16(4):762-70.
PMID: 8412019
DOI: 10.1007/BF00711908.
Abnormalities of biogenic amine metabolism.
Hyland K
J Inherit Metab Dis. 1993; 16(4):676-90.
PMID: 8412014
DOI: 10.1007/BF00711900.
Effect of betaine on S-adenosylmethionine levels in the cerebrospinal fluid in a patient with methylenetetrahydrofolate reductase deficiency and peripheral neuropathy.
Kishi T, Kawamura I, Harada Y, Eguchi T, Sakura N, Ueda K
J Inherit Metab Dis. 1994; 17(5):560-5.
PMID: 7837762
DOI: 10.1007/BF00711591.
Folates and psychiatric disorders. Clinical potential.
Crellin R, Bottiglieri T, Reynolds E
Drugs. 1993; 45(5):623-36.
PMID: 7686459
DOI: 10.2165/00003495-199345050-00001.
Hyperhomocysteinaemia; with reference to its neuroradiological aspects.
van den Berg M, van der Knaap M, Boers G, Stehouwer C, Rauwerda J, Valk J
Neuroradiology. 1995; 37(5):403-11.
PMID: 7477843
DOI: 10.1007/BF00588024.
Dystonia in homocystinuria.
Kempster P, Brenton D, Gale A, STERN G
J Neurol Neurosurg Psychiatry. 1988; 51(6):859-62.
PMID: 3404194
PMC: 1033161.
DOI: 10.1136/jnnp.51.6.859.